Bangladesh vs Korea: New cases tested for RR-/MDR-TB
Bangladesh
100.0%
in 2024
Korea
100.0%
in 2024
Bangladesh rank
1st
Korea rank
1st
New cases tested for RR-/MDR-TB over time
- Bangladesh
- Korea
How they compare
Bangladesh currently reports 100.0% against 100.0% in Korea, a difference of 0.0%.
Across all 13 years both countries report, Korea has been ahead every year.
Bangladesh ranks 1st and Korea ranks 1st of 192 countries.
Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bangladesh | Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 16.0% | 78.6% | 62.6% | Korea |
| 2020s | 56.2% | 94.2% | 38.0% | Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Bangladesh or Korea?
- Bangladesh, at 100.0% against 100.0% in Korea as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Bangladesh and Korea?
- 0.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Korea?
- 13 years are reported by both, from 2011 to 2024.
- How do Bangladesh and Korea rank globally for new cases tested for rr-/mdr-tb?
- Bangladesh ranks 1st and Korea ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.